openPR Logo
Press release

Neurovascular Embolization Devices Market Growing Rapidly by 2031- Stryker Corporation, Johnson & Johnson Inc., Terumo Corporation, B. Braun,, Melsungen AG, Integra LifeSciences Corporation

07-16-2024 07:29 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Neurovascular Embolization Devices Market Growing Rapidly

DataM Intelligence has published a new research report on "Neurovascular Embolization Devices Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/neurovascular-embolization-devices-market

The Neurovascular Embolization Devices market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

Neurovascular embolization devices are medical tools used to treat abnormalities in the blood vessels of the brain and spine, such as aneurysms, arteriovenous malformations (AVMs), and fistulas. These devices, including coils, stents, and liquid embolic agents, are inserted via minimally invasive techniques to block abnormal blood flow or reinforce vessel walls. By occluding or diverting blood flow, neurovascular embolization devices help prevent ruptures and reduce the risk of stroke and other complications, providing a safer alternative to open surgery.

Forecast Growth Projected:

The Global Neurovascular Embolization Devices Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Neurovascular Embolization Devices Market:

Stryker Corporation, Johnson & Johnson Inc., Terumo Corporation, B. Braun,, Melsungen AG, Integra LifeSciences Corporation, Acandis GmBH, Phenox GmBH, Lepu Medical Technology (Beijing)Co, Shape Memory Medical Inc and Medtronic plc.

Segment Covered in the Neurovascular Embolization Devices Market:

By Product Type: Liquid Embolic Systems, Embolization Coils, Aneurysm Clips, Flow Diversion Stents, Others

By Treatment: Oral Ischemic Stroke Solutions, Hemorrhagic Stroke Solutions

By Indicatio: Infants Brain aneurysm, Arteriovenous malformations, Others

By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic Research Centers, Others

Regional Analysis:

The global Neurovascular Embolization Devices Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/neurovascular-embolization-devices-market

Regional Analysis:

The global Neurovascular Embolization Devices Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Neurovascular Embolization Devices Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Neurovascular Embolization Devices manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Neurovascular Embolization Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/neurovascular-embolization-devices-market

FAQs

How big is the Neurovascular Embolization Devices Market?

The Neurovascular Embolization Devices Market size was USD $ 3.7 billion in 2023. It is expected to reach USD $ 6.0 billion by 2031.

How fast is the Neurovascular Embolization Devices Market growing?

The Neurovascular Embolization Devices Market will exhibit a CAGR of 6.4% during the forecast period, 2024-2031.

Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurovascular Embolization Devices Market Growing Rapidly by 2031- Stryker Corporation, Johnson & Johnson Inc., Terumo Corporation, B. Braun,, Melsungen AG, Integra LifeSciences Corporation here

News-ID: 3582410 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Artificial Intelligence in Healthcare Market to Reach USD 187.7 Billion by 2031 | Strong 41.1% CAGR | North America Leads with 43% Share | Key Players: Microsoft, IBM, Google, Siemens Healthineers, NVIDIA
United States Artificial Intelligence in Healthcare Market to Reach USD 187.7 Bi …
Artificial Intelligence in Healthcare Market Overview The Global Artificial Intelligence (AI) in Healthcare Market reached USD 13,248.65 million in 2022 and is projected to grow significantly, reaching USD 187,704.75 million by 2031, expanding at an impressive CAGR of 41.1% during 2024-2031. The market's rapid growth is driven by the increasing integration of AI technologies across various aspects of healthcare, from clinical diagnosis and imaging to drug discovery, patient monitoring, and hospital
United States Smart Syringe Market 2033 | Growth Drivers, Key Players & Investment Opportunities
United States Smart Syringe Market 2033 | Growth Drivers, Key Players & Investme …
Market Size and Growth Smart Syringe Market reached US$ 12.22 Billion in 2024 and is expected to reach US$ 25.97 Billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/smart-syringe-market?sb Key Development: United States: Recent Industry Developments ✅ In September 2025, Apiject Systems, Corp. submitted a regulatory filing to the U.S. Food and Drug Administration
United States Bovine Colostrum Market to Reach $5.19 Billion by 2031, Driven by Rising Demand for Immune-Boosting Supplements & Functional Nutrition Products.
United States Bovine Colostrum Market to Reach $5.19 Billion by 2031, Driven by …
Leander, Texas and TOKYO, Japan - Dec.10.2025 Market Size As per DataM Intelligence research report, "The Global Bovine Colostrum Market reached US$ 3.21 billion in 2022 and is expected to reach US$ 5.19 billion by 2031, growing at a CAGR of 6.21% during the forecast period 2024-2031." Rising awareness of immune-boosting supplements and increasing demand for functional dairy products are driving market growth. Download your exclusive sample report today: (corporate email gets priority
United States Tungsten-Based Materials Market 2031 | Growth Drivers, Key Players & Investment Opportunities
United States Tungsten-Based Materials Market 2031 | Growth Drivers, Key Players …
Market Size and Growth Global Tungsten-Based Materials Market reached US$ 5.9 billion in 2023 and is expected to reach US$ 9.4 billion by 2031, growing with a CAGR of 6.1% during the forecast period 2024-2031. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/tungsten-based-materials-market?sb Key Development: United States: Recent Developments ✅ In November 2025, Global Tungsten & Powders was awarded a grant by the U.S. Department of Energy

All 5 Releases


More Releases for Neurovascular

Emerging Trends Influencing The Growth Of The Neurovascular Catheters Market:Inn …
The Neurovascular Catheters Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Neurovascular Catheters Market Size Expected to Be by 2034? The Neurovascular Catheters Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.
Top Factor Driving Neurovascular Embolization Devices Market Growth in 2025: Ris …
What combination of drivers is leading to accelerated growth in the neurovascular embolization devices market? The rise in the prevalence of hemorrhages is expected to drive the neurovascular embolization devices market. Hemorrhages, caused by factors such as hypertension and anticoagulant medications, are treated using neurovascular embolization devices, which block abnormal blood vessels to reduce bleeding and prevent further brain damage. In February 2024, research by King's College London indicated a projected
Exploring the Neurovascular Catheters Market: Innovative Approaches to Neurovasc …
Allied Market Research Analyst have added a new research study on Title Neurovascular Catheters Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as Zeus Industrial Products, Stryker, Biomerics, Integra Life Sciences, Concentric Medical, DePuy Synthes, Medtronic, RAUMEDIC, Johnson and Johnson, Integer Holdings Corporation. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies and plans. The facts and
Neurovascular Devices industry expected to hit a valuation of US$ 7 billion till …
The global 𝐍𝐞𝐮𝐫𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 market is estimated to attain a valuation of US$ 7 Bn by the end of 2033, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 7.6% during the forecast period, 2023 - 2033. The key objective of the TMR report is to offer a complete assessment of the global market including major leading
Brain Aneurysm Treatment - Modern Neurovascular Techniques
Brain aneurysm is a development of bulge in brain vessels. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which can cause death of the patient. Get PDF Brochure of Research Study @ https://bit.ly/2zir2hL Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm. The global brain aneurysm treatment market
Neurovascular Devices Market: Opportunities and Challenges
The Neurovascular Devices Market is expected to reach USD 2.62 billion by 2021 from USD 1.74 billion in 2016, at a CAGR of 8.6% from 2016 to 2021. Increasing research activities in the field of neurovascular therapies Neurovascular devices are witnessing a growing demand among the major stakeholders globally, due to increasing clinical research activities in the field of neurovascular therapies, which offer credible clinical data related to their safety & efficacy